Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review.
Frontiers in psychiatry January 1, 2025 Mary R Shen, Dylan E Campbell, Anika Kopczynski et al. 10 citations
A scoping review of eight studies found that ketamine may help reduce opioid cravings and use in people with opioid use disorder and can attenuate precipitated withdrawal symptoms, often as an adjunct to buprenorphine. The review searched two databases, yielding 998 studies, of which eight met inclusion criteria: two on opioid use disorder and six on opioid withdrawal. The evidence is preliminary, and more research is needed before widespread clinical use.